ATE162073T1 - Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol - Google Patents

Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol

Info

Publication number
ATE162073T1
ATE162073T1 AT95105766T AT95105766T ATE162073T1 AT E162073 T1 ATE162073 T1 AT E162073T1 AT 95105766 T AT95105766 T AT 95105766T AT 95105766 T AT95105766 T AT 95105766T AT E162073 T1 ATE162073 T1 AT E162073T1
Authority
AT
Austria
Prior art keywords
xanthohumole
treatment
pharmaceutical composition
osteoporosis
osteoporosis containing
Prior art date
Application number
AT95105766T
Other languages
English (en)
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Osamu Komiyama
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE162073T1 publication Critical patent/ATE162073T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95105766T 1994-04-21 1995-04-18 Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol ATE162073T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6082852A JPH07285856A (ja) 1994-04-21 1994-04-21 骨粗鬆症治療剤

Publications (1)

Publication Number Publication Date
ATE162073T1 true ATE162073T1 (de) 1998-01-15

Family

ID=13785904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95105766T ATE162073T1 (de) 1994-04-21 1995-04-18 Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol

Country Status (14)

Country Link
US (1) US5679716A (de)
EP (1) EP0679393B1 (de)
JP (1) JPH07285856A (de)
KR (1) KR100350564B1 (de)
AT (1) ATE162073T1 (de)
AU (1) AU695696B2 (de)
CA (1) CA2147419A1 (de)
DE (1) DE69501419T2 (de)
DK (1) DK0679393T3 (de)
ES (1) ES2116642T3 (de)
FI (1) FI951856A7 (de)
HU (1) HUT71603A (de)
NO (1) NO951498L (de)
TW (1) TW284687B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008208A (en) * 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
DE19939350B4 (de) * 1999-08-19 2005-04-07 Plantextrakt Gmbh & Co. Kg Hopfenextrakt und Verfahren zu dessen Herstellung
KR20060095786A (ko) * 2000-01-27 2006-09-01 다카라 바이오 가부시키가이샤 치료제
EP1277473A4 (de) * 2000-04-10 2005-12-28 Takara Bio Inc Hilfsmittel
US6352726B1 (en) * 2001-01-09 2002-03-05 S. S. Steiner, Inc. Method of killing protozoa
US20040156950A1 (en) * 2001-04-05 2004-08-12 Green Martin Richard Use of hop components in foods
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
US20060233902A1 (en) * 2002-02-14 2006-10-19 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism
AU2002257721A1 (en) * 2002-04-24 2003-11-10 Unilever Plc Use of hop components in foods
DE10240065B4 (de) * 2002-08-30 2004-10-28 Hallertauer Hopfenveredlungsgesellschaft M.B.H. Verfahren zur Gewinnung von in Hopfen enthaltenem Xanthohumol und damit erhältlicher Xanthohumol-reicher Hopfenextrakt
DE50302729D1 (de) * 2002-12-18 2006-05-11 Doehler Gmbh Xanthohumol-haltiges Getränk
DE602004016486D1 (de) * 2003-04-08 2008-10-23 Kirin Brewery Zusammensetzung zur hemmung oder prävention der verringerung der knochendichte
DE102004063125B4 (de) * 2004-12-22 2007-03-15 Ta-Xan-Ag Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke
EP1909584A4 (de) * 2005-07-29 2010-07-07 Bioactives Inc Prenylflavonoid-formulierungen
DE102006062264A1 (de) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
EP2392325A1 (de) 2010-06-04 2011-12-07 Universitätsklinikum Münster Neue Verbindungen zur Prävention und/oder Behandlung von Osteoarthrose
KR101323150B1 (ko) * 2011-04-25 2013-10-30 충남대학교산학협력단 잔토휴몰을 함유하는 골다공증 예방 및 치료용 조성물
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
BR112015001595A2 (pt) * 2012-07-26 2018-06-19 Ta-Xan Ag composição farmacêutica, uso de um extrato torrado, e, método para intensificar um ou mais efeito (s) terapêutico (s) de xantohumol e para a produção de uma composição farmacêutica
JP6009498B2 (ja) * 2014-06-24 2016-10-19 国立大学法人京都大学 アルツハイマー病予防薬
US20180193287A1 (en) 2015-07-02 2018-07-12 John I. Haas, Inc. Hops-based substance and use of the substance
CN105477686B (zh) * 2015-11-30 2019-02-15 长春工业大学 一种包覆黄腐酚的纳米纤维膜

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794744A (en) * 1972-05-10 1974-02-26 White Tomkins Ltd Purification of hop extracts
US4065574A (en) * 1975-08-29 1977-12-27 The Upjohn Company New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds

Also Published As

Publication number Publication date
US5679716A (en) 1997-10-21
KR950031060A (ko) 1995-12-18
AU1653595A (en) 1995-10-19
EP0679393A3 (de) 1995-11-15
FI951856L (fi) 1995-10-22
JPH07285856A (ja) 1995-10-31
KR100350564B1 (ko) 2002-12-16
DE69501419D1 (de) 1998-02-19
DK0679393T3 (da) 1998-09-14
HU9501121D0 (en) 1995-06-28
HUT71603A (en) 1996-01-29
FI951856A7 (fi) 1995-10-22
FI951856A0 (fi) 1995-04-19
NO951498L (no) 1995-10-23
DE69501419T2 (de) 1998-06-25
EP0679393A2 (de) 1995-11-02
TW284687B (de) 1996-09-01
EP0679393B1 (de) 1998-01-14
AU695696B2 (en) 1998-08-20
NO951498D0 (no) 1995-04-20
CA2147419A1 (en) 1995-10-22
ES2116642T3 (es) 1998-07-16

Similar Documents

Publication Publication Date Title
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE69732170D1 (de) Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan
DE69034148D1 (de) Kombinationstherapie zur Prophylaxe und/oder Behandlung von gutartiger prostatischer Hyperplasie
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE60239343D1 (de) Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff
SE9901272D0 (sv) New improved formulation
DE69507185D1 (de) Arzneimittel zur Behandlung von Osteoporose
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
HUP0100024A3 (en) Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
NO994395L (no) Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
DE69424747D1 (de) Pharmazeutische Zusammensetzung zur Vorbeugung oder Behandlung von Knochenbrüchen
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
DE60028682D1 (de) Wachstumhormone Inhibitoren Enthaltende pharmazeutische Zubereitungen oder ihre biologisch aktive Fragmente zur Behandlung von uterinen Myomas
UA30143C2 (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
DE69833317D1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
UA13401C2 (uk) Ветеринарний препарат для профілактики та лікування хвороб вірусної та бактеріальної природи

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee